Barclays Smart Investor research
UK unable to throw money at the situation
Fund will invest in a range of 35-40 companies
New drug launches need private finance
Most Q1 IPOs since 2007
The accelerated approval of the first new Alzheimer's treatment in almost two decades looks set to drive a new wave of biotech innovation and investment.
Covering two key megatrends
How data will prove key in sector's success
Managed by Mike Clulow and US growth equity team